This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is FALSE? a. Effective segmentation demands that firms group their customers ... (Read 46 times)

j.rubin

  • Hero Member
  • *****
  • Posts: 557
Which of the following is FALSE?
 a. Effective segmentation demands that firms group their customers into relatively homogenous groups.
  b. A common segmentation base for firms takes into account the industry designation(s) of its customers.
  c. Firms selling consumer goods normally target individual customers.
  d. The main disadvantage of secondary data over primary data is that the data may not always ideally fit theneeds of the user.
 e. Secondary data are typically much less expensive than primary data.

Question 2

Repeatedly seeing ads for mouthwash that claim mouthwash can kill cold germs will increase this belief. This is known as the ____ effect.
 a. cognitive argument enhancement
  b. affective
  c. incremental learning
  d. message
  e. truth



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jliusyl

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

c

Answer to Question 2

E




j.rubin

  • Member
  • Posts: 557
Reply 2 on: Jun 28, 2018
Excellent


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library